Key Opinion Leader Advisory Board Recruitment Sequence

Role: Senior Medical Affairs Communications Director specializing in clinical investigator engagement and advisory board recruitment.

Context

• Therapeutic domain: {{therapeutic_area}}
• Target physician tier: {{investigator_tier}}
• Clinical development phase: {{clinical_trial_phase}}
• Fair market value compensation model: {{honorarium_structure}}
• Regulatory governance framework: {{regulatory_jurisdiction}}
• Protocol objective: {{primary_endpoint_summary}}

Task

Draft a 3-touch personalized email recruitment script sequence to secure participation from leading medical specialists for a formal advisory panel, balancing scientific rigor with institutional compliance.

Method

1. Analyze {{investigator_tier}} engagement patterns to establish peer-to-peer scientific tone and minimize administrative friction.
2. Draft Email 1 (The Scientific Invitation) highlighting {{clinical_trial_phase}} data gaps, {{primary_endpoint_summary}}, and the strategic mandate of the board.
3. Frame the advisory charter in Email 1 with precise time commitments, confidentiality terms, and preliminary scheduling windows.
4. Draft Email 2 (The Data Deep-Dive Follow-Up) introducing blinded preliminary findings or specific trial design challenges requiring their specific subspecialty expertise.
5. Draft Email 3 (The Administrative Final Call) outlining governance boundaries, contract execution steps, and {{honorarium_structure}} under {{regulatory_jurisdiction}}.
6. Integrate conditional logic snippets for academic medical center department chairs versus community-based high-volume principal investigators.
7. Include mandatory Sunshine Act, FMV, and anti-kickback safe harbor boilerplate placeholders tailored to {{regulatory_jurisdiction}}.

Constraints

• MUST maintain an objective, non-promotional medical affairs tone free from commercial marketing language.
• MUST NOT reference off-label commercial efficacy claims or pre-approval commercialization timelines.
• Every email must contain clear subject lines, preview text, estimated reading time, and explicit call-to-action buttons.
• Word count per email script must remain strictly between 150 and 260 words.

Output format

• Section 1: Sequence Strategy Architecture (Touchpoint Cadence & Logic Triggers)
• Section 2: Email Script 1 (Initial Scientific Invitation + Subject Lines)
• Section 3: Email Script 2 (Clinical Context Follow-up + Dynamic Body Variants)
• Section 4: Email Script 3 (Governance, FMV & Closing Response Protocol)
• Section 5: Regulatory Compliance & Exclusion Handling Scripts

Self-review

• Confirm no promotional or commercial launch phrasing is present in any email draft.
• Verify all references to {{regulatory_jurisdiction}} and {{honorarium_structure}} adhere strictly to medical exchange guidelines.
• Check that each script respects the word count constraint (150-260 words per email).